RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Developing new therapies for patients with glioblastoma (GBM) requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Buxton, Meredith, Alexander, Brian, Berry, Donald, Cavenee, Webster, Colman, Howard, de Groot, John, Ellingson, Benjamin, Gordon, Gary, Khasraw, Mustafa, Lassman, Andrew, Lee, Wenbin, Lim, Michael, Mellinghoff, Ingo, Perry, James, Sulman, Erik, Tanner, Kirk, Weller, Michael, Wen, Patrick, Yung, W K Alfred, Cloughesy, Timothy, Investigators, G B M Agile
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Randomized Trials in Development
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651338/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.816
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky